These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes. Carandini T; Arighi A; Sacchi L; Fumagalli GG; Pietroboni AM; Ghezzi L; Colombi A; Scarioni M; Fenoglio C; De Riz MA; Marotta G; Scarpini E; Galimberti D Alzheimers Res Ther; 2019 Oct; 11(1):84. PubMed ID: 31615545 [TBL] [Abstract][Full Text] [Related]
24. Knowing the natural course of biomarkers in AD: longitudinal MRI, CSF and PET data. Van Der Flier WM; Scheltens P J Nutr Health Aging; 2009 Apr; 13(4):353-5. PubMed ID: 19300878 [No Abstract] [Full Text] [Related]
25. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824 [TBL] [Abstract][Full Text] [Related]
26. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease. Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800 [TBL] [Abstract][Full Text] [Related]
27. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting. Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470 [TBL] [Abstract][Full Text] [Related]
28. What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects? Andriuta D; Moullart V; Schraen S; Devendeville A; Meyer ME; Godefroy O; J Alzheimers Dis; 2016; 51(3):793-800. PubMed ID: 26923012 [TBL] [Abstract][Full Text] [Related]
34. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597 [TBL] [Abstract][Full Text] [Related]
35. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. Risacher SL; Saykin AJ Annu Rev Clin Psychol; 2013; 9():621-48. PubMed ID: 23297785 [TBL] [Abstract][Full Text] [Related]
36. Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. Pérez-Grijalba V; Romero J; Pesini P; Sarasa L; Monleón I; San-José I; Arbizu J; Martínez-Lage P; Munuera J; Ruiz A; Tárraga L; Boada M; Sarasa M J Prev Alzheimers Dis; 2019; 6(1):34-41. PubMed ID: 30569084 [TBL] [Abstract][Full Text] [Related]
37. Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Trojanowski JQ; Vandeerstichele H; Korecka M; Clark CM; Aisen PS; Petersen RC; Blennow K; Soares H; Simon A; Lewczuk P; Dean R; Siemers E; Potter WZ; Weiner MW; Jack CR; Jagust W; Toga AW; Lee VM; Shaw LM; Alzheimers Dement; 2010 May; 6(3):230-8. PubMed ID: 20451871 [TBL] [Abstract][Full Text] [Related]
38. Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. Meyer PF; Pichet Binette A; Gonneaud J; Breitner JCS; Villeneuve S JAMA Neurol; 2020 Apr; 77(4):508-516. PubMed ID: 31961372 [TBL] [Abstract][Full Text] [Related]
39. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Shaffer JL; Petrella JR; Sheldon FC; Choudhury KR; Calhoun VD; Coleman RE; Doraiswamy PM; Radiology; 2013 Feb; 266(2):583-91. PubMed ID: 23232293 [TBL] [Abstract][Full Text] [Related]
40. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers. Koychev I; Hofer M; Friedman N J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]